AMGEN INC — Director's Dealing 2012

Jul 31, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AMGEN INC (AMGN)
CIK: 0000318154
Period of Report: 2012-07-27

Reporting Person: BONANNI FABRIZIO (EVP, Operations)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2012-07-27	Common Stock	M	42109	$71.88	Acquired	115608	Direct
2012-07-27	Common Stock	M	41902	$62.55	Acquired	157510	Direct
2012-07-27	Common Stock	M	30000	$56.79	Acquired	187510	Direct
2012-07-27	Common Stock	M	84000	$42.13	Acquired	271510	Direct
2012-07-27	Common Stock	M	63000	$50.44	Acquired	334510	Direct
2012-07-27	Common Stock	M	42000	$58.43	Acquired	376510	Direct
2012-07-27	Common Stock	G	303011	—	Acquired	363639	Indirect
2012-07-27	Common Stock	G	303011	—	Disposed	73499	Direct
2012-07-27	Common Stock	S	303011	$82.138	Disposed	60628	Indirect
2012-07-30	Common Stock	S	12137	$84.334	Disposed	48491	Indirect

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2012-07-27	Nqso (Right to Buy)	$71.88	M	42109	Disposed	2013-04-03	Common Stock (42109)	Direct
2012-07-27	Nqso (Right to Buy)	$62.55	M	41902	Disposed	2014-04-26	Common Stock (41902)	Direct
2012-07-27	Nqso (Right to Buy)	$56.79	M	30000	Disposed	2014-10-29	Common Stock (30000)	Direct
2012-07-27	Nqso (Right to Buy)	$42.13	M	84000	Disposed	2015-04-29	Common Stock (84000)	Direct
2012-07-27	Nqso (Right to Buy)	$50.44	M	63000	Disposed	2016-04-28	Common Stock (63000)	Direct
2012-07-27	Nqso (Right to Buy)	$58.43	M	42000	Disposed	2020-04-26	Common Stock (42000)	Direct

Footnotes

F1: These shares are being transferred to the reporting person's Family Trust.

F2: These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 3,000 RSUs which fully vest on 4/28/2013; 6,000 RSUs which vest in two equal annual installments of 3,000 each commencing 4/26/2013; 40,000 RSUs which vest fully on 12/31/2013; 15,800 RSUs which vest in two equal installments of 5,214 each on 4/25/2013 and 4/25/2014 and one installment of 5,372 on 4/25/2015; and 8,654 RSUs which vest in three installments of 2,855, 2,856 and 2,943 on 4/27/2014, 4/27/2015 and 4/27/2016, respectively. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis.

F3: These shares include 45 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.

F4: The price reported is an average price. The prices ranged from $81.56 to $82.48 per share. Full information regarding the number of shares sold at each separate price within the range set forth above is available upon request by the SEC staff, the issuer or a security holder of the issuer.

F5: The price reported is an average price. The prices ranged from $84.32 to $84.37 per share. Full information regarding the number of shares sold at each separate price within the range set forth above is available upon request by the SEC staff, the issuer or a security holder of the issuer.